Navigation Links
New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen
Date:1/27/2010

g estrogen, may be directly related to the compounding process." In 2005, the American College of Obstetricians and Gynecologists (ACOG) issued an opinion stating there was "no scientific evidence supporting the claims of increased efficacy or safety of individualized hormone therapy prepared by compounding pharmacies."(7)

About Transdermal Delivery Systems

Transdermal estrogen avoids first-pass metabolism, a process where the amount of a drug taken in is reduced before it reaches systemic circulation because a portion is metabolized in the liver. Avoiding first-pass metabolism allows for lower doses of hormones and establishes more consistent and more physiologic estrogen and metabolite blood levels. To achieve therapeutic levels, oral hormones require higher doses of estrogen than transdermals due to the first-pass metabolism in the liver.(2, 6)

Worldwide, the most commonly used transdermal delivery (TDD) systems for administering estradiol are patches and gels. Within the last few years, non-patch formulations of transdermal estrogen, such as Divigel®, have been developed that share the advantages of transdermal therapy but avoid the inconveniences of the patch, such as skin reactions to adhesives, disadhesion and visibility.(1) Studies have shown no difference in absorption, bioavailability, or peak concentrations between patches and gels, and administration of estradiol by non-patch transdermal therapies has been shown to provide consistent levels of serum estradiol.(4,5)

Curren
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
2. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
3. Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
4. Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
5. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
8. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
9. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
10. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
11. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will present at the 16th Annual B. Riley ... 13, 2015. The conference will be held May 12-14, 2015 ... Heska management will be available during the day on ...
(Date:5/1/2015)... , May 1, 2015 Braeburn ... its current therapeutic focus beyond addiction and ... psychiatric disorders. Braeburn has acquired an implantable, ... antipsychotic risperidone for treatment of schizophrenia from ... acquires global rights to other potential applications ...
(Date:5/1/2015)...  Boston Scientific Corporation (NYSE: BSX ) is ... long-term growth strategies at a meeting with the investment ... . President and Chief Executive Officer Mike Mahoney ... to bring forward meaningful innovation to transform patient care, ... value. "We are focused on addressing ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... LYNDHURST, N.J., Aug. 30 A molecular,diagnostic ... 85,developmental disorders affecting children now is commercially ... testing and,reimbursement by leading health plans across ... ), the nation,s leading provider of diagnostic,testing, ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ... commercializing proprietary product candidates principally,for use in ... completed patient,enrollment in a pivotal Phase III ... intravenous acetaminophen (IV,acetaminophen), for the treatment of ...
Cached Medicine Technology:Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 2Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 3Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 4Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 2Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 3Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 4Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 5
(Date:5/4/2015)... Missouri (PRWEB) May 04, 2015 “St. ... as the “Gateway to the West,” so it is ... for Veterans Program”, says Dr. Ben Litalien, Chief Development ... Franchise Association’s VetFran program and will provide veterans with ... , Zerorez® is proud to have a number of ...
(Date:5/3/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, ... reached the 2,000 ‘Like’ mark on their Facebook page. ... that educate the patients on the many services the ... as well as current events. , Women’s Excellence has ... Facebook, Twitter, Google +, Pinterest, Instagram and You Tube. ...
(Date:5/3/2015)... 03, 2015 “ BolehVPN ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how to protect ... these days is on computers and even more so online. ... meet people all over the world. In terms of work, ...
(Date:5/3/2015)... May 03, 2015 HealthPostures, a ... solutions, announces its appearance at the , May 5 ... that HealthPostures will exhibit at the conference include its ... sit stand solutions is the 6100 TaskMate Executive. Features ... control, an adjustable keyboard tray, extended platform work surface ...
(Date:5/2/2015)... CA (PRWEB) May 02, 2015 ProText Kinetic ... for use in Final Cut Pro X. ProText Kinetic ... use in Final Cut Pro X . Easily ... keyframe with Pixel Film Studios' ProText Kinetic 2. , Using ... Start by staggering two ProText Kinetic presets in the FCPX ...
Breaking Medicine News(10 mins):Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2
... of students nationwide prepare to leave high school, a UC ... the medical journal Pediatrics shows a clear link ... as kindergarten and lower high school test scores. , ... they start school had the strongest negative effect on how ...
... now have a new and simple way to diagnose ... to David Kaelber, M.D., Ph.D., M.P.H., MetroHealth System pediatrician, ... Reserve University School of Medicine researcher and faculty member. ... of cases of prehypertension in children and adolescents go ...
... prior research on the cholesterol-lowering drugs , , MONDAY, May 25 ... reduces the risk of a second stroke, new research shows. ... strokes found a 35 percent lower incidence of second strokes ... took statins compared to those who didn,t, according to a ...
... for bulk vaccine valued at $190 million -SWIFTWATER, Pa. and ... of the sanofi-aventis Group (EURONEXT: SAN and NYSE: ... what is expected to be a series of orders from ... commence production of a vaccine to help protect against the ...
... The general health of toddlers in,the SAR has room ... Hong,Kong Institute of Asia-Pacific Studies at the Chinese ... today to announce the results, a researcher from,CUHK as ... registered dietician,all agreed that, based on the survey, many ...
... to manufacturers by month,s end, CDC says , , SUNDAY, ... progress towards a viable H1N1 swine flu vaccine this ... Control and Prevention saying they had two promising candidate ... CDC received, from one institution, a candidate vaccine virus," ...
Cached Medicine News:Health News:Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find 2Health News:Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find 3Health News:Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find 4Health News:Pediatrician creates easier way to identify kids' high BP 2Health News:Statins Can Help Prevent Second Stroke 2Health News:Statins Can Help Prevent Second Stroke 3Health News:Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine 2Health News:Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine 3Health News:Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine 4Health News:Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine 5Health News:CUHK Releases Results of 'Survey on Toddler Health in Hong Kong' 2Health News:CUHK Releases Results of 'Survey on Toddler Health in Hong Kong' 3Health News:CUHK Releases Results of 'Survey on Toddler Health in Hong Kong' 4Health News:U.S. Closer to Viable Swine Flu Shot 2Health News:U.S. Closer to Viable Swine Flu Shot 3Health News:U.S. Closer to Viable Swine Flu Shot 4Health News:U.S. Closer to Viable Swine Flu Shot 5Health News:U.S. Closer to Viable Swine Flu Shot 6Health News:U.S. Closer to Viable Swine Flu Shot 7Health News:U.S. Closer to Viable Swine Flu Shot 8Health News:U.S. Closer to Viable Swine Flu Shot 9Health News:U.S. Closer to Viable Swine Flu Shot 10Health News:U.S. Closer to Viable Swine Flu Shot 11Health News:U.S. Closer to Viable Swine Flu Shot 12Health News:U.S. Closer to Viable Swine Flu Shot 13
Round serrated handle, dull finish....
Cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Medicine Products: